NYSE
ENOV

Enovis Corp

Specialty Industrial Machinery
Industrials

Prices are adjusted according to historical splits.

Enovis Corp Stock Price

Vitals

Today's Low:
$54.13
Today's High:
$55.06
Open Price:
$54.54
52W Low:
$43.88
52W High:
$67.23
Prev. Close:
$54.67
Volume:
329176

Company Statistics

Market Cap.:
$3.02 billion
Book Value:
63.188
Revenue TTM:
$1.59 billion
Operating Margin TTM:
-0.56%
Gross Profit TTM:
$883.89 million
Profit Margin:
-3.24%
Return on Assets TTM:
-0.09%
Return on Equity TTM:
-0.57%

Company Profile

Enovis Corp had its IPO on 2008-05-08 under the ticker symbol ENOV.

The company operates in the Industrials sector and Specialty Industrial Machinery industry. Enovis Corp has a staff strength of 6,800 employees.

Stock update

Shares of Enovis Corp opened at $54.54 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $54.13 - $55.06, and closed at $54.61.

This is a -0.11% slip from the previous day's closing price.

A total volume of 329,176 shares were traded at the close of the day’s session.

In the last one week, shares of Enovis Corp have slipped by -3.35%.

Enovis Corp's Key Ratios

Enovis Corp has a market cap of $3.02 billion, indicating a price to book ratio of 0.878 and a price to sales ratio of 0.7335.

In the last 12-months Enovis Corp’s revenue was $1.59 billion with a gross profit of $883.89 million and an EBITDA of $196.72 million. The EBITDA ratio measures Enovis Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Enovis Corp’s operating margin was -0.56% while its return on assets stood at -0.09% with a return of equity of -0.57%.

In Q1, Enovis Corp’s quarterly earnings growth was a positive 153.1% while revenue growth was a positive 8.2%.

Enovis Corp’s PE and PEG Ratio

Forward PE
22.0264
Trailing PE
0
PEG
1.0958

Its diluted EPS in the last 12-months stands at $-0.46 per share while it has a forward price to earnings multiple of 22.0264 and a PEG multiple of 1.0958. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Enovis Corp’s profitability.

Enovis Corp stock is trading at a EV to sales ratio of 0.8191 and a EV to EBITDA ratio of 5.7863. Its price to sales ratio in the trailing 12-months stood at 0.7335.

Enovis Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$4.30 billion
Total Liabilities
$349.50 million
Operating Cash Flow
$-34385000.00
Capital Expenditure
$30.44 million
Dividend Payout Ratio
0%

Enovis Corp ended 2024 with $4.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $4.30 billion while shareholder equity stood at $3.44 billion.

Enovis Corp ended 2024 with $0 in deferred long-term liabilities, $349.50 million in other current liabilities, 54000.00 in common stock, $552.38 million in retained earnings and $1.99 billion in goodwill. Its cash balance stood at $21.90 million and cash and short-term investments were $21.90 million. The company’s total short-term debt was $23,116,000 while long-term debt stood at $285.00 million.

Enovis Corp’s total current assets stands at $833.11 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $280.75 million compared to accounts payable of $151.74 million and inventory worth $438.96 million.

In 2024, Enovis Corp's operating cash flow was $-34385000.00 while its capital expenditure stood at $30.44 million.

Comparatively, Enovis Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$54.61
52-Week High
$67.23
52-Week Low
$43.88
Analyst Target Price
$66.8

Enovis Corp stock is currently trading at $54.61 per share. It touched a 52-week high of $67.23 and a 52-week low of $67.23. Analysts tracking the stock have a 12-month average target price of $66.8.

Its 50-day moving average was $59.65 and 200-day moving average was $57.56 The short ratio stood at 4.24 indicating a short percent outstanding of 0%.

Around 882.7% of the company’s stock are held by insiders while 9853.3% are held by institutions.

Frequently Asked Questions About Enovis Corp

The stock symbol (also called stock or share ticker) of Enovis Corp is ENOV

The IPO of Enovis Corp took place on 2008-05-08

Similar Industry Stocks (Specialty Industrial Machinery)

Last Price
Chg
Chg%
$200.8
6
+3.08%
$316.3
-21.65
-6.41%
$353.45
-10.5
-2.89%
$0.21
-0.01
-2.59%
$200
-12.15
-5.73%
$716.25
-8.6
-1.19%
$1.04
0.15
+16.85%
Netlist Inc (NLST)
$1.61
0
0%
$149.55
4.4
+3.03%
$103.8
-9.25
-8.18%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Address

2711 Centerville Road, Wilmington, DE, United States, 19808